GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Z

ZhuZhou QianJin Pharmaceutical Co 600479.SS · CNY

Health Care · Shanghai · 🇨🇳 China

Compare

10.60

-0.56%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥3.63bn

FY2016FY2025

Net income

CN¥287.8m

FY2016FY2025

Free cash flow

CN¥356.1m

FY2016FY2025

Shareholders' equity

CN¥3.03bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥3.63bnCN¥3.63bnCN¥3.80bnCN¥4.03bnCN¥3.66bnCN¥3.63bnCN¥3.53bnCN¥3.33bnCN¥3.18bnCN¥2.86bn
Research and developmentCN¥185.6mCN¥220.2mCN¥149.1mCN¥113.8mCN¥108.7mCN¥104.1mCN¥105.4mCN¥84.1mCN¥78.8mCN¥61.9m
Operating incomeCN¥440.5mCN¥332.1mCN¥461.9mCN¥444.2mCN¥436.2mCN¥424.2mCN¥430.8mCN¥337.4mCN¥296.3mCN¥194.0m
Net incomeCN¥287.8mCN¥230.8mCN¥320.4mCN¥302.5mCN¥302.1mCN¥297.1mCN¥294.3mCN¥255.4mCN¥207.8mCN¥149.4m
Diluted earnings per share0.530.600.800.720.720.710.700.610.500.36

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥4.96bnCN¥4.56bnCN¥4.68bnCN¥4.62bnCN¥4.06bnCN¥4.23bnCN¥3.81bnCN¥3.47bnCN¥3.29bnCN¥3.03bn
Cash and short-term investments—CN¥1.35bnCN¥2.00bnCN¥1.91bnCN¥1.42bnCN¥1.41bnCN¥1.38bnCN¥1.10bnCN¥690.3mCN¥736.2m
Total liabilitiesCN¥1.61bnCN¥1.42bnCN¥1.65bnCN¥1.82bnCN¥1.36bnCN¥1.47bnCN¥1.18bnCN¥1.04bnCN¥1.05bnCN¥948.2m
Debt—CN¥433.0mCN¥116.7mCN¥124.2mCN¥148.9mCN¥196.9mCN¥22.4mCN¥27.7mCN¥38.3mCN¥47.8m
Shareholders' equityCN¥3.03bnCN¥2.46bnCN¥2.39bnCN¥2.22bnCN¥2.15bnCN¥2.27bnCN¥2.18bnCN¥2.03bnCN¥1.88bnCN¥1.75bn
Shares outstanding540m382m402m423m418m419m419m418m419m418m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥480.2mCN¥398.8mCN¥443.1mCN¥733.5mCN¥485.6mCN¥542.4mCN¥155.5mCN¥383.5mCN¥283.5mCN¥140.9m
Capital spending−CN¥124.2m−CN¥47.3m−CN¥44.0m−CN¥34.4m−CN¥71.9m−CN¥97.2m−CN¥40.6m−CN¥46.4m−CN¥57.3m−CN¥81.5m
Free cash flowCN¥356.1mCN¥351.4mCN¥399.1mCN¥699.0mCN¥413.7mCN¥445.1mCN¥114.9mCN¥337.1mCN¥226.2mCN¥59.4m
Dividends paid−CN¥152.7m−CN¥152.8m−CN¥149.5m−CN¥248.6m−CN¥429.5m−CN¥209.3m−CN¥167.4m−CN¥105.0m−CN¥71.4m−CN¥54.4m

Latest quarters

By quarter end

Sept 2026Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024
RevenueCN¥922.4mCN¥948.0mCN¥970.3mCN¥916.2mCN¥900.3mCN¥813.0mCN¥1.01bnCN¥915.2m
Operating incomeCN¥84.1mCN¥131.3mCN¥97.1mCN¥139.9mCN¥105.3mCN¥115.3mCN¥80.0mCN¥91.5m
Net incomeCN¥76.9mCN¥105.8mCN¥75.0mCN¥100.5mCN¥59.6mCN¥74.6mCN¥53.2mCN¥62.7m
Diluted earnings per share0.140.200.140.190.110.140.100.16
Cash from operations————CN¥288.0mCN¥79.0m−CN¥124.0mCN¥349.0m
Capital spending−CN¥45.0m−CN¥9.0m−CN¥23.0m−CN¥64.0m−CN¥23.0m−CN¥31.0m−CN¥4.0m−CN¥13.0m
Free cash flow————CN¥265.0mCN¥48.0m−CN¥128.0mCN¥336.0m
Total assetsCN¥5.17bnCN¥5.00bnCN¥5.13bnCN¥4.96bnCN¥4.90bnCN¥4.76bnCN¥4.66bnCN¥4.56bn
Cash and short-term investments————CN¥567.1mCN¥858.8mCN¥934.0mCN¥1.35bn
Debt————CN¥424.5mCN¥11.5mCN¥6.2mCN¥381.1m
Shareholders' equityCN¥3.10bnCN¥3.02bnCN¥3.10bnCN¥3.03bnCN¥2.50bnCN¥2.44bnCN¥2.52bnCN¥2.46bn

Financial ratios

Data as of 15 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Operating margin12.1%9.5%12.3%11.2%12.0%11.8%—
Net margin7.9%6.4%8.4%7.5%8.2%8.2%—
Return on equity9.5%9.4%13.4%13.6%14.0%13.1%—
Return on assets5.8%5.1%6.9%6.5%7.4%7.0%—
Free cash flow yield9.7%10.1%10.5%15.8%11.6%13.3%—
Revenue growth0.1%-4.4%-5.7%9.9%1.0%2.9%—
Earnings growth24.7%-28.0%5.9%0.1%1.7%0.9%—
Current ratio1.45x2.05x2.28x2.07x2.37x2.31x—
Debt to equity—0.15x0.04x0.04x0.05x0.07x0.01x
Equity ratio61.0%54.0%51.1%47.9%53.0%53.6%—
Interest coverage8276.10x40.58x78.19x70.37x75.34x146.38x—
R&D as a share of sales5.1%6.1%3.9%2.8%3.0%2.9%—
Buybacks as a share of market value-41.1%4.9%5.0%-1.1%0.1%-0.0%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-3.4%0.0%4.0%
Operating income-0.3%0.8%16.6%
Net income-1.6%-0.6%12.0%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin10.6%11.1%11.3%10.3%
Net margin7.1%7.6%7.8%7.3%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings19.117.713.513.417.412.212.512.723.536.8
Price to sales1.51.11.11.01.41.01.01.01.51.9

Dividends and splits

Per share, in the currency the company pays

Paid for 21 years. Last went ex-dividend on 30 Jun 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year0.380.360.350.350.601.000.500.40
  • 6-for-5 split · 15 Jun 2018
  • 7-for-5 split · 9 Jun 2010
  • 6-for-5 split · 25 May 2009
  • 6-for-5 split · 25 Apr 2008
  • 6-for-5 split · 28 May 2007
  • 3-for-2 split · 24 Apr 2006

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.